To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Kohlberg, Partners-backed PCI Pharma snags Permira’s LSNE at $1.5bn valuation
The PE-backed CDMO grows its mix of work as it gains significant capabilities in lyophilization, an important manufacturing process commonly used in the fast-growing biologics market.
